Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2006 | 06-2006 | 12-2005 | 06-2005 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 0 | N/A | -5,740 | 0 |
| Depreciation Amortization | N/A | 0 | N/A | 1,130 | 0 |
| Other Working Capital | N/A | 0 | N/A | -300 | 0 |
| Other Operating Activity | 0 | -5,950 | 0 | -100 | -5,270 |
| Operating Cash Flow | $N/A | $-5,950 | $N/A | $-5,010 | $-5,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -150 | N/A | -10 | -790 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 820 |
| Investing Cash Flow | $N/A | $-150 | $N/A | $-10 | $30 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -450 | 0 | 10,060 | 10,890 |
| Financing Cash Flow | $N/A | $-450 | $N/A | $10,060 | $10,890 |
| Exchange Rate Effect | N/A | 30 | N/A | 530 | -110 |
| Beginning Cash Position | N/A | 18,410 | N/A | 7,890 | 5,820 |
| End Cash Position | N/A | 11,880 | N/A | 13,460 | 11,360 |
| Net Cash Flow | $N/A | $-6,520 | $N/A | $5,560 | $5,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -5,950 | N/A | -5,010 | -5,270 |
| Free Cash Flow | 0 | -5,950 | 0 | -5,010 | -5,270 |